Larson Financial Group »

Larimar Therapeutics shares owned by Larson Financial Group

Quarter-by-quarter ownership of Larimar Therapeutics (LRMR) shares owned by Larson Financial Group from 13F filings

Historical chart of Larson Financial Group investment in Larimar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Larimar Therapeutics held by Larson Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Larimar Therapeutics by Larson Financial Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $13 4 3.25
2024-12-31 $464 120 3.87

More positions owned by Larson Financial Group

Spdr Series Trust Portfolio S&p500 (SPLG)
Apple (AAPL)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
American Centy Etf Tr Us Quality Grow (QGRO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Mid Cap Etf (VO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Franklin Templeton Etf Tr Us Mid Cp Mltfct (FLQM)
Capital Group Global Equity SHS (CGGE)
Invesco Exchange Traded Fd T Rafi Us 1000 Etf (PRF)
Ishares Tr Msci Intl Qualty (IQLT)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Broadcom (AVGO)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)

View all positions for Larson Financial Group

Top funds holding Larimar Therapeutics

Deerfield Management Company
RA Capital Management
Blue Owl Capital Holdings
Millennium Management
Opaleye Management
BlackRock
Rtw Investments
Vanguard Group
Caption Management
Logos Global Management
Adage Capital Partners GP
Alyeska Investment Group
Citadel Advisors
Woodline Partners
Goldman Sachs Group

View all funds holding Larimar Therapeutics